Bank of New York Mellon’s DarioHealth DRIO Stock Holding History
Bought
Maintained
Sold
Other funds holding DRIO
NCM
PF
AWAM
YDMI
CI
CCP
Bank of New York Mellon's DRIO Position: Q4 2023 in Review
Bank of New York Mellon sold out of DarioHealth (DRIO) in Q4 2023, closing a stake of 1,354 shares — an estimated $88.8K sold.
Bank of New York Mellon first reported a position in DRIO in Q2 2021 and held it in 9 quarters. The position peaked at $870K in Q2 2021. 35 funds tracked by Wall St. Rank hold DRIO as of Q4 2023.
- Bank of New York Mellon reported no remaining DarioHealth position as of Q4 2023 after selling out during the quarter.
- Bank of New York Mellon sold 1,354 DarioHealth shares in Q4 2023, an estimated $88.8K.
- Bank of New York Mellon first reported a position in DarioHealth in Q2 2021 and held it in 9 quarters.
- Bank of New York Mellon's DarioHealth position peaked at $870K in Q2 2021.
- 35 funds tracked by Wall St. Rank held DarioHealth as of Q4 2023.
Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.